Press Releases

– KO-7246 regenerated functional β-cell mass and produced durable glycemic control in Type 1 and Type 2 diabetes models – – KO-7246 has potential to complement existing diabetes therapies with a novel mechanism of action, evidenced by post-treatment durability and combination benefit with semaglutide – – Findings highlight a potentially disease-modifying approach designed to restore the body’s own endogenous insulin-producing capacity – – Caspian is building a leadership position in menin-directed therapies for diabetes and other cardiometabolic diseases – – Management to host webcast and conference call on October 13, 2026, at 4:30 p.m. ET / 1:30 p.m. PT – SAN DIEGO, Sept. 29, 2026

BEIJING, Sept. 29, 2026 /PRNewswire/ -- New Oriental Education and Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services in China, today announced that it will report its financial results for the first quarter ended August 31, 2026, before the U.S. market opens on October 28, 2026. New Oriental's management will host an earnings conference call at 8 AM on October 28, 2026, U.S. Eastern Time (8 PM on October 28, 2026, Beijing/Hong Kong Time). Participants can join the conference using the below options: Dialling-in to the conference call:Please register in advance of the conference, using the link provided below. Upon regis

MEDFORD, Ore., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Lithia & Driveway (NYSE:LAD) today announced its third quarter 2026 results will be released before the market opens on Wednesday, October 21, 2026. A conference call to discuss the earnings results is scheduled for the same day at 10:00 a.m. Eastern Time. How to Participate The conference call may be accessed by telephone at (877) 407-8029. To listen live on our website, or for replay, visit investors.lithiadriveway.com and click on quarterly earnings. About Lithia & Driveway (LAD)Lithia & Driveway (NYSE:LAD) is the largest global automotive retailer making Auto Done Easy by providing simple, transparent, and convenient experiences thro

NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Teads (NASDAQ:TEAD), the omnichannel outcomes platform, and Koddi, a leading commerce media platform, today announced a global partnership delivering an open, universal OpenRTB standard for onsite retail media inventory. Building on Teads' position as an early innovator in bringing real-time bidding (RTB) capabilities to native retail listings, this strategic collaboration directly tackles the top challenges facing advertisers today: according to IAB Europe’s Attitudes to Retail Media report, the fragmentation of retail media networks (51%) and a lack of standardization (53%) remain the primary barriers for buy-side stakeholders. The integratio

Pearson strengthens enterprise offering with adaptive assessment and skills intelligence to meet growing demand for workforce transformation in the era of AILONDON, Sept. 29, 2026 /PRNewswire/ -- Pearson (FTSE: PSON.L), the world's lifelong learning company, today announced it has agreed to acquire Workera, the AI-native skills intelligence platform used by leading enterprises to verify what their workforce can actually do. Workera combines agentic AI, psychometrics and adaptive assessment to measure demonstrated proficiency through role-specific scenarios and simulations. Its proven technology and top tier talent will accelera

Marks a major milestone in Nasdaq Calypso’s strategy to serve as the trusted orchestration layer connecting agents across capital market and treasury workflows Introduces agentic capabilities, including a natural language assistant to automate analysis of the platform’s system-of-record data NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today launched a framework for integrating AI capabilities within capital market and treasury operations, addressing some of the bottlenecks that are preventing scaled institutional adoption. At its core, Nasdaq has established an agentic AI operating environment within its Nasdaq Calypso platform, providing financial institutions with

LONDON, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Willis, a WTW business (NASDAQ:WTW), today launches RiskIQ Nexus, a new risk intelligence platform designed to help organizations bring risk and insurance data together in one place. This gives risk managers faster access to the information and insights they need to understand their programs, prepare for renewals and make more informed risk and insurance decisions. Part of WTW's leading RiskIQ ecosystem, Nexus helps organizations consolidate policy, premium, loss, exposure and other risk and insurance information from multiple sources into a single, connected view. Its AI capabilities support multi-language document ingestion and enable users

DUBAI, United Arab Emirates and HOLMDEL, N.J. , Sept. 29, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced a strategic partnership with Al Majlis Group, the Dubai-based public affairs and advisory group founded by H.E. Dherar Belhoul Al Falasi. Under the partnership, BIO-key and Al Majlis Group will work together to bring BIO-key's identity security platform to government and private sector organizations across the UAE and Saudi Arabia. The collaboration pairs Al Majlis Group's advisory expertise and regional standi

Foundayo 17.2 mg was associated with 1.5% greater weight loss and 0.3% greater A1C reduction than oral semaglutide 25 mg at 52 weeksThese additional analyses build on findings of the ACHIEVE-3 head-to-head study, where Foundayo 9 mg and 17.2 mg delivered greater A1C and weight reductions than oral semaglutide 14 mgINDIANAPOLIS, Sept. 29, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY), the maker of Zepbound (tirzepatide), today announced results from a new analysis showing that Foundayo (orforglipron) 17.2 mg was associated with significantly greater weight loss and better blood sugar control than oral semaglutide 25 mg in adults with type 2 diabetes. The findings are based on an indir

Dr. Cord Dohrmann to step down as of September 30, 2026Search ongoing for a successorHAMBURG, Germany, Sept. 29, 2026 /PRNewswire/ -- Evotec SE (NASDAQ:EVO) (Frankfurt Prime Standard: EVT) today announced that Chief Scientific Officer (CSO) Dr. Cord Dohrmann will step down effective September 30, 2026. The decision for Dr. Dohrmann to step down from his position was made by mutual consent between Dr. Dohrmann and the Company. Dr. Christian Wojczewski, Chief Executive Officer of Evotec, said:"I would like to thank Cord for his long service and many contributions to Evotec over the past 16 years. Throughout his tenure, he has played a significant role in strengthening the scientific excellence

Leiden, the Netherlands, September 29, 2026: Pharming (NASDAQ:PHAR), a global biotechnology company focused on rare immune and genetic diseases, today announced that the Board of Directors and Fabrice Chouraqui have mutually agreed that Mr. Chouraqui will step down as Chief Executive Officer and Executive Director, with immediate effect. To ensure continuity of leadership, the Board of Directors has appointed Mrs. Leverne Marsh, Chief Commercial Officer, and Mr. Kenneth Lynard, Chief Financial Officer, as Interim Co-CEOs, effective immediately. Mrs. Marsh will lead the patient-focused operations while Mr. Lynard will lead the global corporate functions. The Board has started a formal searc

HANOI, Vietnam, Sept. 29, 2026 (GLOBE NEWSWIRE) -- EHang Holdings Limited ("EHang" or the "Company") (NASDAQ:EH), the world’s leading Advanced Air Mobility (AAM) technology platform company, today announced that its Global Fast Track Program has expanded to Vietnam: Vietnam has become the second country to join the Program following Sri Lanka, with Hanoi as its first stop, marking EHang’s first city‑level partnership in the country. The Company’s partner, HungViet Technology and Investment Trading JSC ("HungViet"), has signed a Memorandum of Understanding (MOU) with the Hanoi Department of Science and Technology ("Hanoi DOST") in Hanoi. In accordance with Hanoi’s dedicated procedures for r

Affiliate partnership with Redbrick Mortgage Advisory gives SingSaver users bank-by-bank rate comparison and advice through to applicationThe launch takes SingSaver into Singapore's largest household debt category, worth S$296.4 billion, where the gap between bank home loan rates and the HDB concessionary rate of 2.6% can add up to hundreds of dollars a month for borrowers SINGAPORE, Sept. 29, 2026 (GLOBE NEWSWIRE) -- SingSaver, Singapore's leading personal finance comparison platform and part of Nasdaq-listed MoneyHero Group (NASDAQ:MNY), today launched a Home Loans comparison category in partnership with Redbrick Mortgage Advisory. The launch takes SingSaver into the largest category of

The shelf prospectus supplement, the corresponding base shelf prospectus and any amendment to the documents will be accessible through SEDAR+ within two business daysCALGARY, AB, Sept. 28, 2026 /CNW/ -- Canadian Pacific Kansas City Limited (TSX:CP) (NYSE:CP) ("CPKC") announced that its wholly owned subsidiary, Canadian Pacific Railway Company ("CPRC"), is issuing C$500 million of 4.20% Notes due 2030, C$550 million of 4.60% Notes due 2033, C$300 million of 4.90% Notes due 2037 and C$450 million of 5.40% Notes due 2056, which will be guaranteed by CPKC (the "Offering").The Offering is expected to close on October 6, 2026, subject to the satisfaction of customary closing conditions.The net pro

BANGKOK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) (the "Company"), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the Company expected to be approximately $1.25 million, before deducting placement agent fees and other offering expenses payable by the Company. The offering consists of 17,857,143 Ordinary Shares or Pre-Funded Warrants in lieu thereof. The public offering price per Comm

AUSTIN, Minn., Sept. 28, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced its quarterly dividend on the common stock, authorized by the Board of Directors at $0.2925 per share. The dividend will be paid on November 16, 2026, to stockholders of record at the close of business on October 13, 2026. This marks the 393rd consecutive quarterly dividend paid by the company. Since becoming a public company in 1928, Hormel Foods Corporation has paid a regular quarterly dividend without interruption.About Hormel FoodsHormel Foods Corporation, based in Austin, Minnesota,

BEIJING, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Julong Holding Limited ("Julong" or the "Company") (NASDAQ:JLHL), a growth-oriented provider of intelligent integrated solutions, today announced that, on September 28, 2026, it entered into a securities purchase agreement (the "Securities Purchase Agreement") with certain investors for a private placement (the "Private Placement") of the Company’s securities. Under the terms of the Securities Purchase Agreement, the Company agreed to issue and sell (i) 750,000 Class A ordinary shares (the "Class A Ordinary Shares"), par value US$0.0001 per share, of the Company (the "Initial Shares"), at a purchase price of US$0.300 per share, and (ii) 2,250,00

BRANFORD, Conn., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced interim development results comparing its next-generation Proteus™ platform with its commercially available Platinum® Pro instrument. Using a developmental sequencing kit that detects 18 amino acids, Proteus significantly outperformed Platinum Pro across every key measure, from sequencing scale and accuracy to peptide identification and protein sequence coverage, even though the Proteus instrument, consumable, loading protocol and analysis software are sti

SAN DIEGO, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that its data will be presented at the Euretina Innovation Spotlight (EIS) being held on September 30, 2026, and Euretina being held on October 1-4, 2026, in Vienna, Austria. EIS Presentation DetailsSession: EURETINA Innovation Spotlight – Inherited and Rare Retinal DiseasesTitle: Belite Bio Company OverviewPresenter: Hendrik Scholl, M.D., Chief Medical Officer, Belite BioDate and Time: September 30, 20

— Filing seeks approval for a biomarker-directed, all-oral treatment option for patients whose tumors have MET overexpression or amplification, after progression on an EGFR-TKI therapy — — Application supported by SAFFRON, the first global Phase III trial to demonstrate statistically significant and clinically meaningful improvements in progression-free and overall survival in this setting — — SAFFRON builds on evidence from the SACHI Phase III and SAVANNAH Phase II trials — HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Sept. 28, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that AstraZeneca has submitted a New Drug Application ("